This post may contain affiliate links which may compensate us based on your interaction. Please read the disclosures for more information.
Pain, drug-hopping and insurance meddling are common among rheumatoid arthritis patients. Could a blood test change that? New Africa / Shutterstock.com
Editor’s Note: This story originally appeared on KFF Health News. SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two drugs in the same class. But the insurer insisted, so Schulte went on Remicade.